AstraZeneca Blood Clotting Risk Examined

The safety and validity of vaccination with COVID-19 vaccine AstraZeneca has been questioned recently due to its link to a rare blood clotting condition called ‘thrombosis with thrombocytopenia syndrome’ (TTS).

Dr Anthony Zulli, Associate Professor of Vascular Pharmacology at the University of Victoria, joined On the Record to talk about the safety of the vaccine and to put the potential risk of developing TTS into perspective.

on the record astrazeneca 13-4-21